ROIV
Roivant Sciences Ltd. · Healthcare
Director Daniel Allen Gold sold $26.3M of Roivant Sciences Ltd.
Sold$26,304,500
$20.23Price
1,300,000Shares
−7%Stake
What ROIV did after the filing
- The stock from Mon, Nov 24 open, $20.17
- +8.0%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Jan 8 close.
Traded Wed, Nov 19. Filed Fri, Nov 21, 8:22 PM ET, after the close. Returns use the Nov 24 open and the Jan 8 close. Not investment advice.